BDBM300903 (2S, 3R)-3-((R or S)-2-(1-(2, 5-bis (trifluoromethyl) benzyl) azetidin-3-yl)-2, 3, 4, 5-tetrahydrobenzo[b]oxepin-8-yl)-3-cyclopropyl-2-methylpropanoic acid::US10131651, Example 3
SMILES: C[C@@H]([C@@H](C1CC1)c1ccc2CCC[C@H](Oc2c1)C1CN(Cc2cc(ccc2C(F)(F)F)C(F)(F)F)C1)C(O)=O
InChI Key: InChIKey=BAKXTOWRITUZSO-DTNWAODDSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 1 (Homo sapiens (Human)) | BDBM300903 ((2S, 3R)-3-((R or S)-2-(1-(2, 5-bis (trifluorometh...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The assay is performed in 384-well format. HEK cells stably expressing human GPR40 are plated at 15,000 cells per well in growth medium (DMEM/10% fet... | US Patent US10131651 (2018) BindingDB Entry DOI: 10.7270/Q2XP770F | |||||||||||
More data for this Ligand-Target Pair |